SCHEMBL7003406

SCHEMBL7003406

C=C(C)CC1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14354172 0.97 EPHX1 (0.40)
SCHEMBL3069324 0.97 EPHX1 (0.40)
SCHEMBL22305020 0.82 DPP4 (0.35)
SCHEMBL12166729 0.79 SHBG (0.34)
SCHEMBL12166719 0.77 DPP4 (0.31)
SCHEMBL5021 0.77
Ethylene SCHEMBL10406044 0.76 ESR2 (0.34)
SCHEMBL20376693 0.75 NCF1 (0.48)
SCHEMBL9979182 0.74 EPHX1 (0.43)
SCHEMBL95966 0.74 EPHX1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4666619-A TER- OR TETRAPOLYMER, THICKENERS EXXON RESEARCH & ENGINEERING CO. (US) 1987-05-19 US claimed
EP-0188103-A2 An ethylene polymer useful as a lubricating oil viscosity modifier EXXON RESEARCH AND ENGINEERING COMPANY (US) 1986-07-23 EP claimed
EP-4177249-A1 IMMUNOMODULATOR Hitgen Inc. (CN) 2023-05-10 EP disclosed
US-20210403445-A1 SYSTEMS AND METHODS FOR REGIOSELECTIVE CARBONYLATION OF 2,2-DISUBSTITUTED EPOXIDES CORNELL UNIVERSITY 2021-12-30 US disclosed
WO-2020102816-A1 SYSTEMS AND METHODS FOR REGIOSELECTIVE CARBONYLATION OF 2,2-DISUBSTITUTED EPOXIDES CORNELL UNIVERSITY (US) 2020-05-22 WO disclosed
EP-2812303-A1 ALDEHYDES AS PERFUMING INGREDIENTS Firmenich SA (CH) 2014-12-17 EP disclosed
WO-2013117433-A1 ALDEHYDES AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2013-08-15 WO disclosed
EP-1086078-B1 NEUROPEPTIDE Y5 RECEPTOR ANTAGONISTS SCHERING CORP (US) 2003-02-05 EP disclosed
US-6329395-B1 UREA DERIVATIVES FOR TREATING AN EATING DISORDER OR DIABETES COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF A COMPOUND OF CLAIM 1 TO A MAMMAL SCHERING CORPORATION 2001-12-11 US disclosed
EP-1086078-A1 NEUROPEPTIDE Y5 RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2001-03-28 EP disclosed
WO-1999064394-A1 NEUROPEPTIDE Y5 RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 1999-12-16 WO disclosed